AVITA Medical (RCEL) Receivables (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Receivables data on file, last reported at $9.1 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables fell 22.91% year-over-year to $9.1 million; the trailing twelve-month figure through Dec 2025 stood at $9.1 million (down 22.91% YoY), and the FY2025 full-year result was $9.1 million, down 23.27% from the prior year.
• Receivables for Q4 2025 stood at $9.1 million, up from $9.0 million in the prior quarter.
• Across five years, Receivables topped out at $12.0 million in Q1 2025 and bottomed at $3.4 million in Q4 2021.
• The 5-year median for Receivables is $6.6 million (2023), against an average of $7.1 million.
• The widest annual swing landed in 2021, when Receivables soared 204.4%; it then plunged 42.97% in 2022.
• A 5-year view of Receivables shows it stood at $3.4 million in 2021, then grew by 28.81% to $4.4 million in 2022, then jumped by 74.35% to $7.7 million in 2023, then surged by 53.18% to $11.8 million in 2024, then fell by 22.91% to $9.1 million in 2025.
• The last three Receivables figures came in at $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.

Peer Comparison